UT Southwestern Medical Center
General Surgery
Dr. Ann M. Leitch, MD
|
|
Give Review
Doctor Ann M. Leitch, MD is an expert in the field of General Surgery. He graduated from University of Texas Southwestern Medical School. He received 2 awards: "CMS Meaningful Use Stage 1 Certification" and "Fellow (FACS)". Leitch is a published doctor and has 40 publications published. The lastest was: 'American Cancer Society Lymphedema Workshop. Workgroup I: Treatment of the axilla with surgery and radiation--preoperative and postoperative risk assessment.' He accepts Medicare.
Publications
- Oxidative stress inhibits distant metastasis by human melanoma cells.
- Factors affecting sentinel lymph node identification rate after neoadjuvant chemotherapy for Breast cancer patients enrolled in ACOSOG Z1071 (Alliance).
- Impact of weight change during neoadjuvant chemotherapy on pathologic response in triple-negative Breast cancer.
- Tumor Biology Correlates With Rates of Breast-Conserving Surgery and Pathologic Complete Response After Neoadjuvant Chemotherapy for Breast Cancer: Findings From the A...
- Fluorouracil, epirubicin, and cyclophosphamide (FEC-75) followed by paclitaxel plus trastuzumab versus paclitaxel plus trastuzumab followed by FEC-75 plus trastuzumab ...
- Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive Breast cancer: the ACOSOG Z1071 (Alliance) clinical trial.
- Management of locoregional and systemic recurrence of Breast cancer: to stage or not to stage and how.
- Reproducibility of cytologic atypia in repeat nipple duct lavage.
- Patient and duct selection for nipple duct lavage.
- Axillary dissection vs no axillary dissection in women with invasive Breast cancer and sentinel node metastasis: a randomized clinical trial.
- Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Su...
- Adherence to the National Quality Forum (NQF) Breast cancer measures within cancer clinical trials: a review from ACOSOG Z0010.
- LocoRegional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College ...
- What's new in surgical oncology.
- Influence of surgical technique on mastectomy and reexcision rates in Breast-conserving therapy for cancer.
- CASE 4. Fibrocystic Breast disease in a 16-year-old female with PTEN hamartoma tumor syndrome.
- Association of occult metastases in sentinel lymph nodes and bone marrow with survival among women with early-stage invasive Breast cancer.
- Breast cancer: screening and early detection.
- Multimodality treatment of locally advanced Breast carcinoma.
- Patterns of participation and successful patient recruitment to American College of Surgeons Oncology Group Z0010, a phase II trial for patients with early-stage breas...
- Hepatocyte growth factor (HGF), keratinocyte growth factor (KGF), and their receptors in human Breast cells and tissues: alternative receptors.
- Breast cancer in a county hospital population: impact of Breast screening on stage of presentation.
- MRI vs. histologic measurement of Breast cancer following chemotherapy: comparison with x-ray mammography and palpation.
- Breast cancer screening: success amid conflict.
- Characterization of paired tumor and non-tumor cell lines established from patients with Breast cancer.
- False-positive sentinel lymph nodes in Breast cancer patients caused by benign glandular inclusions: report of three cases and review of the literature.
- Volume of Excision and Cosmesis with Routine Cavity Shave Margins Technique.
- Validating the performance of the mammary sentinel lymph node team.
- American Cancer Society Lymphedema Workshop. Workgroup I: Treatment of the axilla with surgery and radiation--preoperative and postoperative risk assessment.
- Loss of heterozygosity in benign Breast epithelium in relation to Breast cancer risk.
- Controversies in Breast cancer screening.
- Delays in time to treatment and survival impact in Breast cancer.
- DNA methylation in benign Breast epithelium in relation to age and Breast cancer risk.
- Clinical relevance of reverse transcriptase-polymerase chain reaction for the detection of axillary lymph node metastases in Breast cancer.
- Promoter hypermethylation in benign Breast epithelium in relation to predicted Breast cancer risk.
- Limitations of the Gail model in the specialized Breast cancer risk assessment clinic.
- Atypia and DNA methylation in nipple duct lavage in relation to predicted Breast cancer risk.
- Patient variables that predict atypical cytology by nipple duct lavage.
- American Cancer Society guidelines for the early detection of Breast cancer: update 1997.
Schools
University of Texas Southwestern Medical Center At Dallas
University Calif San Diego
University Of California Los Angeles
Md Anderson
Procedures Preformed
- Biopsy of Breast
- Breast Reconstruction
- Excision of Breast Tumor
- Excision, Shaving, or Destruction of Skin and Subcutaneous Tissue (incl. Mohs Micrographic Surgery), Tissue Transfer
- View All
Conditions Treated
- Abdominal Pain
- Atelectasis
- Breast Cancer
- Breast Lump
- View All
Doctors Specialties
- General Surgery
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- American Republic
- Amerigroup (Wellpoint)
- Assurant Health
- Blue Card PPO
- Blue Choice
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- LocalPlus
- Open Access Plus
- Commercial Insurance Company
- Coventry Health Care
- First Health (Coventry Health Care) PPO
- Golden Rule
- GEHA
- HealthFirst
- HealthSmart
- Choice Care PPO
- Preferred PPO
- Medicare MCR
- PHCS Network PPO
- Principal Life
- Thrivent Financial
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
- USI Affinity
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACS)
Education
-
University of Texas MD Anderson Cancer Center -
UCLA Medical Center -
University of California San Diego -
University of Texas Southwestern Medical School
Hospital
-
University of Texas Southwestern Medical Center -
Children's Health System of Texas -
Parkland Health & Hospital System
Drug Facts
| NPI NUMBER | 1386679769 | |
| NPPES Provider LastName | LEITCH | |
| NPPES Provider FirstName | ANN | |
| NPPES Provider ZIPCode | 753907208 | |
| NPPES Provider State | TX | |
| Specialty Description | Surgical Oncology | |
| Total Claim Count | 65.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 19.0 | |
| Percent Opioid Claims | 29.23 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1386679769 |
| Last Name Of The Provider | LEITCH |
| First Name Of The Provider | ANN |
| View All |
Similar Doctors
|
|
Dr. Raul G. Puelma, MD |
|
Dr. Narinder K. Monga, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. J A. Bianco, DO |
|
|
Dr. William J. Bennett, MD |
|
|
Dr. Paul E. Gray Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. George E. Bone, MD |
|
|
Dr. Jennel M. Carreras, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Samuel E. Kirkendall, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nathan W. Kincaid, MD |
|
|
Dr. Elizabeth Z. Naftalis, MD |